TRANSCRIPTOME-WIDE STUDY OF ALTERNATIVE SPLICING ACROSS MULTIPLE CANCER TYPES
Public DepositedAdd to collection
You do not have access to any existing collections. You may create a new collection.
Downloadable Content
Download PDFCitation
MLA
Tsai, Yi Hsuan. Transcriptome-wide Study Of Alternative Splicing Across Multiple Cancer Types. Chapel Hill, NC: University of North Carolina at Chapel Hill Graduate School, 2015. https://doi.org/10.17615/ma81-e710APA
Tsai, Y. (2015). TRANSCRIPTOME-WIDE STUDY OF ALTERNATIVE SPLICING ACROSS MULTIPLE CANCER TYPES. Chapel Hill, NC: University of North Carolina at Chapel Hill Graduate School. https://doi.org/10.17615/ma81-e710Chicago
Tsai, Yi Hsuan. 2015. Transcriptome-Wide Study Of Alternative Splicing Across Multiple Cancer Types. Chapel Hill, NC: University of North Carolina at Chapel Hill Graduate School. https://doi.org/10.17615/ma81-e710- Last Modified
- March 19, 2019
- Creator
-
Tsai, Yi-Hsuan
- Affiliation: School of Medicine, Curriculum in Bioinformatics and Computational Biology
- Abstract
- Alternative splicing (AS) is a very important cellular process in eukaryote, which contribute to both the proteome diversity and control of gene expression levels. It is tightly regulated in different tissues and developmental stages and dysregulation of splicing can lead to many human diseases. Cancer is one of the extreme examples where splicing is highly altered. However the underline mechanism responsible for such dysregulation is largely unclear. Moreover, identification of cancer specific AS events is complicated by the large noise of different tissues-specific splicing. In the chapters that follow, we first explore the evolution and functionality of RNA binding proteins which is one of the key regulators of AS. We then use the RNA-seq data from TCGA (The Cancer Genome Atlas) to identify AS events that are significantly altered between tumor and normal samples across multiple cancer types. We also show that these cancer-specific AS events are highly conserved, more likely to maintain protein reading frame, and mainly function in cell cycle, cell adhesion/migration, and insulin signaling pathway. Furthermore, these events can serve as new molecular biomarkers to distinguish cancer from normal tissues, to separate cancer subtypes, and to predict patient survival. We also demonstrate that most genes whose expression is closely associated with cancer-specific splicing are key regulators of the cell cycle. Our study uncovers a common set of cancer-specific AS events altered across multiple cancers, providing mechanistic insight into how splicing is mis-regulated in cancers. Lastly we show that kidney tumors harbor significantly higher intron retention than other tumor types and such increase of splicing alteration in kidney cancer is highly correlated with patient survival. Together our works have helped to better understand AS across multiple human cancers and how it might be regulated and its connection to some important cancer pathways.
- Date of publication
- May 2015
- Keyword
- Subject
- DOI
- Identifier
- Resource type
- Rights statement
- In Copyright
- Advisor
- Wang, Zefeng
- Gomez, Shawn
- Laederach, Alain
- Prins, Jan
- Hammond, Scott
- Degree
- Doctor of Philosophy
- Degree granting institution
- University of North Carolina at Chapel Hill Graduate School
- Graduation year
- 2015
- Language
- Publisher
- Place of publication
- Chapel Hill, NC
- Access right
- There are no restrictions to this item.
- Date uploaded
- June 23, 2015
Relations
- Parents:
This work has no parents.
Items
Thumbnail | Title | Date Uploaded | Visibility | Actions |
---|---|---|---|---|
Tsai_unc_0153D_15180.pdf | 2019-04-12 | Public | Download |